Literature DB >> 2338818

Lipid kinetic alterations in tumor-bearing rats: reversal by tumor excision.

R N Younes1, N A Vydelingum, Y Noguchi, M F Brennan.   

Abstract

Cancer cachexia is frequently accompanied by hyperlipidemia. To identify the mechanisms underlying this alteration in lipid metabolism, free fatty acid (FFA) and very low density lipoprotein-associated triacylglycerol (VLDL-TG) kinetics were determined in tumor-bearing (subcutaneously implanted methylcholanthrene-induced sarcoma) Fischer 344 rats. The animals were studied after chronic vascular catheterization, in an unanesthetized, undisturbed state, after 24 hr of fasting. They were separated into three groups: control (n = 5), tumor-bearing (n = 5, tumor burden = 10% body weight), and 7 days after tumor excision (n = 5). VLDL-TG and FFA kinetics were assessed by a constant infusion of [3H]palmitate-labeled VLDL-TG and [14C]palmitate bound to albumin, respectively. FFA rate of appearance (FFA-Ra) and clearance (FFA-Cl) and VLDL-TG rate of appearance (VLDL-TG-Ra) and clearance (VLDL-TG-Cl) were determined at steady state. We observed that the tumor-bearing rats had significantly increased FFA-Ra and VLDL-TG-Ra, decreased VLDL-CL, and maintained FFA-Cl, when compared to control. These alterations returned to normal levels after tumor excision. The results suggest that the hyperlipidemia observed in tumor-bearing rats is due to elevated lipolysis rate, maintained rate of plasma FFA clearance, increased triacylglycerol production and VLDL secretion by the liver, and decreased VLDL-TG clearance from plasma. These alterations were reversed 7 days following tumor excision.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2338818     DOI: 10.1016/0022-4804(90)90067-c

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  5 in total

Review 1.  Metabolic alteration in patients with cancer: nutritional implications.

Authors:  Y Sakurai; S Klein
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

2.  The possible role of TNF-alpha and IL-2 in inducing tumor-associated metabolic alterations.

Authors:  Y Noguchi; T Makino; T Yoshikawa; K Nomura; K Fukuzawa; A Matsumoto; T Yamada
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

3.  Growth hormone and insulin reverse net whole body and skeletal muscle protein catabolism in cancer patients.

Authors:  R F Wolf; D B Pearlstone; E Newman; M J Heslin; A Gonenne; M E Burt; M F Brennan
Journal:  Ann Surg       Date:  1992-09       Impact factor: 12.969

4.  Muscle UCP-3 mRNA levels are elevated in weight loss associated with gastrointestinal adenocarcinoma in humans.

Authors:  P Collins; C Bing; P McCulloch; G Williams
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

5.  Circulating Levels of Agouti-Related Peptide in Endometrial Cancer Survivors.

Authors:  Julie Bienertova-Vasku; Josef Tomandl; Petr Bienert; Josef Chovanec; Zuzana Dostalova; Anna Vasku; Dalibor Valik
Journal:  World J Oncol       Date:  2011-10-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.